Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Publication year range
1.
PLoS One ; 8(3): e58305, 2013.
Article in English | MEDLINE | ID: mdl-23472176

ABSTRACT

Leukotriene E4 (LTE4), the most stable of the cysteinyl leukotrienes (cysLTs), binds poorly to classical type 1 and 2 cysLT receptors although in asthmatic individuals it may potently induce bronchial constriction, airway hyperresponsiveness and inflammatory cell influx to the lung. A recent study has suggested that the purinergic receptor P2Y12 is required for LTE4 mediated pulmonary inflammation in a mouse model of asthma and signals in response to cysLTs. The aim of the study was to characterise the responsiveness of human P2Y12 to cysteinyl leukotrienes. Models of human CysLT1, CysLT2 and P2Y12 overexpressed in HEK293, CHO cells and human platelets were used and responsiveness to different agonists was measured using intracellular calcium, cAMP and ß-arrestin recruitment assays. CysLTs induced concentration dependent calcium mobilisation in cells overexpressing CysLT1 and CysLT2 but failed to induce any calcium response in cells expressing P2Y12 or P2Y12+ Gα16. In contrast, selective P2Y12 agonists ADP and 2-MeS-ADP induced specific calcium flux in cells expressing P2Y12+ Gα16. Similarly, specific response to 2-MeS-ADP, but not to cysLTs was also observed in cells expressing P2Y12 when intracellular cAMP and ß-arrestin signalling were analysed. Platelets were used as a model of human primary cells expressing P2Y12 to analyse potential signalling and cell activation through P2Y12 receptor or receptor heterodimers but no specific LTE4 responses were observed. These results show that LTE4 as well as other cysLTs do not activate intracellular signalling acting through P2Y12 and suggest that another LTE4 specific receptor has yet to be identified.


Subject(s)
Cysteine/metabolism , Leukotriene E4/metabolism , Leukotrienes/metabolism , Receptors, Leukotriene/metabolism , Receptors, Purinergic P2Y12/metabolism , Adenosine Diphosphate/analogs & derivatives , Adenosine Diphosphate/pharmacology , Animals , Arrestins/metabolism , Blood Platelets/metabolism , CHO Cells , Calcium/metabolism , Cricetulus , Cyclic AMP/metabolism , Cysteine/agonists , HEK293 Cells , Humans , Inflammation , Leukotrienes/agonists , Mice , Platelet Activation , Purinergic P2Y Receptor Agonists/pharmacology , Signal Transduction , Thionucleotides/pharmacology , beta-Arrestins
2.
Pharmacol Rev ; 63(3): 539-84, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21771892

ABSTRACT

The seven-transmembrane G protein-coupled receptors activated by leukotrienes are divided into two subclasses based on their ligand specificity for either leukotriene B(4) or the cysteinyl leukotrienes (LTC(4), LTD(4), and LTE(4)). These receptors have been designated BLT and CysLT receptors, respectively, and a subdivision into BLT(1) and BLT(2) receptors and CysLT(1) and CysLT(2) receptors has been established. However, recent findings have also indicated the existence of putative additional leukotriene receptor subtypes. Furthermore, other ligands interact with the leukotriene receptors. Finally, leukotrienes may also activate other receptor classes, such as purinergic receptors. The aim of this review is to provide an update on the pharmacology, expression patterns, and pathophysiological roles of the leukotriene receptors as well as the therapeutic developments in this area of research.


Subject(s)
Gene Expression Regulation , Receptors, Leukotriene/classification , Animals , Cysteine/agonists , Cysteine/antagonists & inhibitors , Cysteine/metabolism , Humans , International Agencies , Leukotriene Antagonists/therapeutic use , Leukotrienes/agonists , Leukotrienes/metabolism , Molecular Targeted Therapy , Organ Specificity , Receptors, Leukotriene/chemistry , Receptors, Leukotriene/genetics , Receptors, Leukotriene/metabolism , Signal Transduction/drug effects , Terminology as Topic
3.
Acta bioquím. clín. latinoam ; 30(4): 343-50, dic. 1996. ilus, tab
Article in Spanish | BINACIS | ID: bin-20773

ABSTRACT

Se formuló un kit liofilizado de IgG, se marcó con 99mTc y se utilizó en ratones Balb/c portadores de un sitio de inflamación. La marcación se basó en la reducción de los puentes disulfuro (S-S) usando 2-mercaptoetanol (2-ME) y metilendifosfonato como ligando la transferencia. Las especies marcadas fueron analizadas comparativamente por cromatografía instantánea en placa delgada (ITLC Gelman SG), cromatografía líquida de alta presión (HPLC) y electroforesis en gel de poliacrilamida (PAGE). Los ensayos de biodistribución y las imágenes fueron realizadas en ratones Balb/c con un absceso de 48 h inducido por la inyección de trementina (pata derecha) y mostraron una clara diferencia entre la proteína marcada y el 99mTcO4Na. Las relaciones pata normal/pata inflamada de 24 h no mostraron diferencias con el 67Ga, pero fueron mayores para la 99mTc-IgG a las 4 h. En conclusión la 99mTc-IgG puede ser usada en las detecciones tempranas de sitios de inflamación/infección con todas las ventajas sobre el 67Ga debido a las propiedades físicas ideales del 99mTc, fácil preparación, bajo costo y mayor disponibilidad (AU)


Subject(s)
Humans , Animals , Mice , Rats , Abscess/diagnosis , Immunoglobulin G/diagnosis , Sodium Pertechnetate Tc 99m/diagnosis , Isotope Labeling/methods , Radioisotopes/diagnosis , Cysteine/agonists , Cysteine/diagnosis , Enzyme-Linked Immunosorbent Assay/methods
4.
Acta bioquím. clín. latinoam ; 30(4): 343-50, dic. 1996. ilus, tab
Article in Spanish | LILACS | ID: lil-195411

ABSTRACT

Se formuló un kit liofilizado de IgG, se marcó con 99mTc y se utilizó en ratones Balb/c portadores de un sitio de inflamación. La marcación se basó en la reducción de los puentes disulfuro (S-S) usando 2-mercaptoetanol (2-ME) y metilendifosfonato como ligando la transferencia. Las especies marcadas fueron analizadas comparativamente por cromatografía instantánea en placa delgada (ITLC Gelman SG), cromatografía líquida de alta presión (HPLC) y electroforesis en gel de poliacrilamida (PAGE). Los ensayos de biodistribución y las imágenes fueron realizadas en ratones Balb/c con un absceso de 48 h inducido por la inyección de trementina (pata derecha) y mostraron una clara diferencia entre la proteína marcada y el 99mTcO4Na. Las relaciones pata normal/pata inflamada de 24 h no mostraron diferencias con el 67Ga, pero fueron mayores para la 99mTc-IgG a las 4 h. En conclusión la 99mTc-IgG puede ser usada en las detecciones tempranas de sitios de inflamación/infección con todas las ventajas sobre el 67Ga debido a las propiedades físicas ideales del 99mTc, fácil preparación, bajo costo y mayor disponibilidad


Subject(s)
Humans , Animals , Mice , Rats , Abscess/diagnosis , Immunoglobulin G , Isotope Labeling , Sodium Pertechnetate Tc 99m , Cysteine/agonists , Cysteine , Enzyme-Linked Immunosorbent Assay , Radioisotopes
SELECTION OF CITATIONS
SEARCH DETAIL
...